Press release
Cervical Cancer Clinical Trials 2024: FDA Approvals, Pipeline, Therapeutic Advancements, Mechanism of Action, Route of Administration and Companies by DelveInsight | Regeneron, Akesobio, AstraZeneca, Genexine, Merck KGaA, Seagen
Cervical Cancer Clinical Trials
"Cervical Cancer Pipeline Insight, 2024" report by DelveInsight outlines comprehensive insights into the present clinical development scenario and growth prospects across the Cervical Cancer Market.
Request for Sample Report @ https://www.delveinsight.com/report-store/cervical-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
The Cervical Cancer Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the drug, including the mechanism of action of the drug, clinical studies, NDA approvals (if any), and product development activities comprising the technology, collaborations, mergers acquisition, funding, designations, and other product-related details.
Some of the key takeaways from the Cervical Cancer Pipeline Report:
• Companies across the globe are diligently working toward developing novel Cervical Cancer treatment therapies with a considerable amount of success over the years.
• Cervical Cancer companies working in the treatment market are Rubius Therapeutics, Nurix, PDS Biotechnology Corporation, Vaccibody AS, Roche, EMD Serono, Eli Lilly and Company, AkesoBiopharma, Regeneron Pharmaceuticals, and others, are developing therapies for the Cervical Cancer treatment
• Emerging Cervical Cancer therapies such as - RTX 321, DeTIL 0255, PDS 0101, VB10.16, Tiragolumab, Bintrafusp alfa, Gemcitabine, Cadonilimab, Cemiplimab, and others are expected to have a significant impact on the Cervical Cancer market in the coming years.
• In March 2024, Merck (MSD) has announced that the Phase III KEYNOTE-A18 (ENGOT-cx11/GOG-3047) clinical trial of Keytruda combined with chemoradiotherapy (CRT) in cervical cancer patients has achieved its primary endpoint. This double-blind, randomized trial is being conducted by MSD in collaboration with the European Network for Gynecological Oncology Trial (ENGOT) groups and the GOG Foundation.
Cervical Cancer Overview
Cervical cancer is a type of cancer that occurs in the cells of the cervix - the lower part of the uterus that connects to the vagina. Various strains of the human papillomavirus (HPV), a sexually transmitted infection, play a role in causing most cervical cancer.
Get a Free Sample PDF Report to know more about Cervical Cancer Pipeline Therapeutic Assessment-
https://www.delveinsight.com/sample-request/cervical-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Emerging Cervical Cancer Drugs Under Different Phases of Clinical Development Include:
• RTX 321: Rubius Therapeutics
• DeTIL 0255: Nurix
• PDS 0101: PDS Biotechnology Corporation
• VB10.16: Vaccibody AS
• Axalimogene filolisbac: Advaxis
• Camrelizumab: Jiangsu HengRui Medicine Co., Ltd.
• Tiragolumab: Roche
• AK104: Akeso
• Bintrafusp alfa: EMD Serono
• Durvalumab :AstraZeneca
• Gemcitabine: Eli Lilly and Company
• HLX10:Shanghai Henlius Biotech
• Cadonilimab: AkesoBiopharma
• Cemiplimab: Regeneron Pharmaceuticals
Route of Administration
Cervical Cancer pipeline report provides the therapeutic assessment of the pipeline drugs by the Route of Administration. Products have been categorized under various ROAs, such as
• Inhalation
• Inhalation/Intravenous/Oral
• Intranasal
• Intravenous
• Intravenous/ Subcutaneous
• NA
• Oral
• Oral/intranasal/subcutaneous
• Parenteral
• Subcutaneous
Molecule Type
Products have been categorized under various Molecule types, such as
• Antibody
• Antisense oligonucleotides
• Immunotherapy
• Monoclonal antibody
• Peptides
• Protein
• Recombinant protein
• Small molecule
• Stem Cell
• Vaccine
Cervical Cancer Pipeline Therapeutics Assessment
• Cervical Cancer Assessment by Product Type
• Cervical Cancer By Stage and Product Type
• Cervical Cancer Assessment by Route of Administration
• Cervical Cancer By Stage and Route of Administration
• Cervical Cancer Assessment by Molecule Type
• Cervical Cancer by Stage and Molecule Type
DelveInsight's Cervical Cancer Report covers around 70+ products under different phases of clinical development like
• Late-stage products (Phase III)
• Mid-stage products (Phase II)
• Early-stage product (Phase I)
• Pre-clinical and Discovery stage candidates
• Discontinued & Inactive candidates
• Route of Administration
Further Cervical Cancer product details are provided in the report. Download the Cervical Cancer pipeline report to learn more about the emerging Cervical Cancer therapies at:
https://www.delveinsight.com/sample-request/cervical-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Some of the key companies in the Cervical Cancer Therapeutics Market include:
Key companies developing therapies for Cervical Cancer are - Regeneron Pharmaceuticals, Akesobio, AstraZeneca, Genexine, Inc., Merck KGaA, Seagen Inc., Vaccibody AS, Qilu Pharmaceutical Co., Ltd., Genor Biopharma Co., Ltd., Roche, Guangzhou Gloria Biosciences Co., Ltd., Lee's Pharmaceutical Limited, BeiGene, Henlix Biotech, Biocad, CSPC ZhongQi Pharmaceutical Technology Co., Ltd., Cellid Co., Ltd., Innovent Biologics, Zeria Pharmaceutical, Advaxis, Inc., Hookipa Biotech GmbH, GlaxoSmithKline, Iovance Biotherapeutics, Inc., NETRIS Pharma, Rubius Therapeutics, Repertoire Immune Medicines, SOTIO Biotech a.s., VM Oncology, LLC, Andes Biotechnologies, Transgene, Xencor, Inc., Exelixis, Ocellaris Pharma, Inc, Fate Therapeutics, Arcus Biosciences, In., MacroGenics, and others.
Cervical Cancer Pipeline Analysis:
The Cervical Cancer pipeline report provides insights into
• The report provides detailed insights about companies that are developing therapies for the treatment of Cervical Cancer with aggregate therapies developed by each company for the same.
• It accesses the Different therapeutic candidates segmented into early-stage, mid-stage, and late-stage of development for Cervical Cancer Treatment.
• Cervical Cancer key companies are involved in targeted therapeutics development with respective active and inactive (dormant or discontinued) projects.
• Cervical Cancer Drugs under development based on the stage of development, route of administration, target receptor, monotherapy or combination therapy, a different mechanism of action, and molecular type.
• Detailed analysis of collaborations (company-company collaborations and company-academia collaborations), licensing agreement and financing details for future advancement of the Cervical Cancer market.
The report is built using data and information traced from the researcher's proprietary databases, company/university websites, clinical trial registries, conferences, SEC filings, investor presentations, and featured press releases from company/university websites and industry-specific third-party sources, etc.
Download Sample PDF Report to know more about Cervical Cancer drugs and therapies-
https://www.delveinsight.com/sample-request/cervical-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Cervical Cancer Pipeline Market Drivers
• Increase in the incidence of oncological disease, large number of ongoing clinical trials are some of the important factors that are fueling the Cervical Cancer Market.
Cervical Cancer Pipeline Market Barriers
• However, high cost of therapy, side-effects associated and other factors are creating obstacles in the Cervical Cancer Market growth.
Scope of Cervical Cancer Pipeline Drug Insight
• Coverage: Global
• Key Cervical Cancer Companies: Rubius Therapeutics, Nurix, PDS Biotechnology Corporation, Vaccibody AS, Roche, EMD Serono, Eli Lilly and Company, AkesoBiopharma, Regeneron Pharmaceuticals, and others
• Key Cervical Cancer Therapies: RTX 321, DeTIL 0255, PDS 0101, VB10.16, Tiragolumab, Bintrafusp alfa, Gemcitabine, Cadonilimab, Cemiplimab, and others
• Cervical Cancer Therapeutic Assessment: Cervical Cancer current marketed and Cervical Cancer emerging therapies
• Cervical Cancer Market Dynamics: Cervical Cancer market drivers and Cervical Cancer market barriers
Request for Sample PDF Report for Cervical Cancer Pipeline Assessment and clinical trials-
https://www.delveinsight.com/sample-request/cervical-cancer-pipeline-insight?utm_source=openpr&utm_medium=pressrelease&utm_campaign=apr
Table of Contents
1 Cervical Cancer Report Introduction
2 Cervical Cancer Executive Summary
3 Cervical Cancer Overview
4 Cervical Cancer- Analytical Perspective In-depth Commercial Assessment
5 Cervical Cancer Pipeline Therapeutics
6 Cervical Cancer Late Stage Products (Phase II/III)
7 Cervical Cancer Mid Stage Products (Phase II)
8 Cervical Cancer Early Stage Products (Phase I)
9 Cervical Cancer Preclinical Stage Products
10 Cervical Cancer Therapeutics Assessment
11 Cervical Cancer Inactive Products
12 Company-University Collaborations (Licensing/Partnering) Analysis
13 Cervical Cancer Key Companies
14 Cervical Cancer Key Products
15 Cervical Cancer Unmet Needs
16 Cervical Cancer Market Drivers and Barriers
17 Cervical Cancer Future Perspectives and Conclusion
18 Cervical Cancer Analyst Views
19 Appendix
20 About DelveInsight
Trending Reports:
• Epithelioid Sarcoma Market: https://www.delveinsight.com/report-store/epithelioid-sarcoma-market
• Ventricular Fibrillation Market: https://www.delveinsight.com/report-store/atrial-fibrillation-market
• Emesis Market: https://www.delveinsight.com/report-store/emesis-market
• Lymphocytopenia Market: https://www.delveinsight.com/report-store/lymphocytopenia-market
• Capnography Device Market: https://www.delveinsight.com/report-store/capnography-devices-market
• Alstrom Syndrome Market: https://www.delveinsight.com/report-store/alstrom-syndrome-epidemiology-forecast
• Walking Impairment In Multiple Sclerosis Market: https://www.delveinsight.com/report-store/walking-impairment-in-multiple-sclerosis-market
• Hearing Aid Devices Market: https://www.delveinsight.com/report-store/audiology-devices-market
• Advanced Recurrent Ovarian Cancer Market: https://www.delveinsight.com/report-store/advanced-recurrent-ovarian-cancer-market
• Primary Progressive Multiple Sclerosis Ppms Market: https://www.delveinsight.com/report-store/primary-progressive-multiple-sclerosis-ppms-pipeline-insight
• Chronic Myelogenous Leukemia Market: https://www.delveinsight.com/report-store/chronic-myelocytic-leukemia-cml-market
• Surgical Stapling Devices Market: https://www.delveinsight.com/report-store/surgical-stapling-devices-market
• Biochips Market: https://www.delveinsight.com/blog/biochips-market-landscape
• Radioligand Therapies Market: https://www.delveinsight.com/report-store/radioligand-therapies-market-forecast
• Goitre Market: https://www.delveinsight.com/report-store/goitre-market
• Pharma Competitive Intelligence: https://www.delveinsight.com/blog/competitive-intelligence-in-healthcare-sector
• Post-bariatric Hypoglycemia Market: https://www.delveinsight.com/report-store/post-bariatric-hypoglycemia-market
• Hemophilia With Inhibitor Market: https://www.delveinsight.com/report-store/hemophilia-a2030-market
• Bone Anchored Hearing Systems Market: https://www.delveinsight.com/report-store/bone-anchored-hearing-systems-market
• Acute Agitation And Aggression Market: https://www.delveinsight.com/report-store/acute-agitation-and-aggression-market
• Primoridal Dwarfism Market: https://www.delveinsight.com/report-store/primordial-dwarfism-market
• Dermal Mycosis Market: https://www.delveinsight.com/report-store/dermal-mycosis-pipeline-insight
• Penicillinbinding Proteins Market: https://www.delveinsight.com/report-store/penicillin-binding-proteins-market
• Adenoid Cystic Carcinoma Market: https://www.delveinsight.com/report-store/adenoid-cystic-carcinom-market
• Hereditary Spastic Paraplegias Market: https://www.delveinsight.com/report-store/hereditary-spastic-paraplegias-market
• Ventricular Dysfunction Market: https://www.delveinsight.com/report-store/ventricular-dysfunction-market
• Alagille Syndrome Market: https://www.delveinsight.com/report-store/alagille-syndrome-market
• Image Guided Surgery Devices Market: https://www.delveinsight.com/report-store/image-guided-surgery-devices-market
• Implantable Infusion Pumps Market: https://www.delveinsight.com/report-store/implantable-infusion-pumps-market
• Bone Densitometers Market: https://www.delveinsight.com/report-store/bone-densitometers-market
• Hpv-induced Cancers Market: https://www.delveinsight.com/report-store/hpv-induced-cancers-market
• Cerebral Vein Thrombosis Market: https://www.delveinsight.com/report-store/cerebral-vein-thrombosis-market
• Contraceptive Devices Market: https://www.delveinsight.com/report-store/contraceptive-devices-market
• Alpha-mannosidosis Market: https://www.delveinsight.com/report-store/alpha-mannosidosis-market
• Pulse Oximeters Market: https://www.delveinsight.com/report-store/pulse-oximeters-market
• Blood Glucose Monitoring Systems Market: https://www.delveinsight.com/report-store/blood-glucose-monitoring-systems-market
• Ankylosing Spondylitis Bekhterevs Disease Market: https://www.delveinsight.com/report-store/ankylosing-spondylitis-as-market
• Atrophic Vaginitis Market: https://www.delveinsight.com/report-store/atrophic-vaginitis-market
• Diffuse Cutaneous Systemic Sclerosis Market: https://www.delveinsight.com/report-store/diffuse-cutaneous-systemic-sclerosis-dcssc-market
• Idiopathic Membranous Nephropathy Market: https://www.delveinsight.com/report-store/idiopathic-membranous-nephropathy-imn-market
• Intrahepatic Cholangiocarcinoma Market: https://www.delveinsight.com/report-store/cholangiocarcinoma-cca-market-insights-epidemiology-and-market-forecast
• Acute Gout Flare Market: https://www.delveinsight.com/report-store/acute-gout-flare-market
• Aids Related Kaposi's Sarcoma Market: https://www.delveinsight.com/report-store/aids-related-kaposis-sarcoma-market
• Chronic Idiopathic Urticaria Market: https://www.delveinsight.com/report-store/chronic-spontaneous-urticaria-market
• Crohns Disease Cd Market: https://www.delveinsight.com/report-store/crohns-disease-cd-market
• Helicobacter Pylori Infections Market: https://www.delveinsight.com/report-store/helicobacter-pylori-infections-market
• Juvenile Rheumatoid Arthritis Market: https://www.delveinsight.com/report-store/juvenile-rheumatoid-arthritis-market
• Acromegaly Market: https://www.delveinsight.com/report-store/acromegaly-market
• Androgenetic Alopecia Market: https://www.delveinsight.com/report-store/androgenetic-alopecia-market
• Chronic Plaque Psoriasis Market: https://www.delveinsight.com/report-store/chronic-plaque-psoriasis-market
• Post-transplant Lymphoproliferative Disease Market: https://www.delveinsight.com/report-store/post-transplant-lymphoproliferative-disorder-market
• Wet-age Related Macular Degeneration Market: https://www.delveinsight.com/report-store/age-related-macular-degeneration-amd-market
• Central Retinal Venous Occulsion Market: https://www.delveinsight.com/report-store/retinal-vein-occlusion-market
• Gastric Neuroendocrine Tumors Market: https://www.delveinsight.com/report-store/gastric-neuroendocrine-tumors-market
• Post Traumatic Stress Disorder Market: https://www.delveinsight.com/report-store/post-traumatic-stress-disorder-ptsd-market
Contact Us:
Ankit Nigam
Manager Marketing
info@delveinsight.com
+14699457679
https://www.delveinsight.com/consulting/conference-coverage-services
About DelveInsight
DelveInsight is a leading Life Science market research and business consulting company recognized for its off-the-shelf syndicated market research reports and customized solutions to firms in the healthcare sector.
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Cervical Cancer Clinical Trials 2024: FDA Approvals, Pipeline, Therapeutic Advancements, Mechanism of Action, Route of Administration and Companies by DelveInsight | Regeneron, Akesobio, AstraZeneca, Genexine, Merck KGaA, Seagen here
News-ID: 3645888 • Views: …
More Releases from DelveInsight Business Research
Niemann-Pick Type C Pipeline Report Showcases Emerging Drugs and Leading Compani …
DelveInsight's, "Niemann Pick C Disease Pipeline Insight, 2025" report provides comprehensive insights about 10+ companies and 15+ pipeline drugs in Niemann Pick C Disease pipeline landscape. It covers the Niemann-Pick Type C pipeline drug profiles, including clinical and nonclinical stage products. It also covers the Niemann-Pick Type C pipeline therapeutics assessment by product type, stage, route of administration, and molecule type. It further highlights the inactive pipeline products in this…
Pemphigus Vulgaris Market Positioned for Accelerated Development Through 2034, D …
DelveInsight's "Pemphigus Vulgaris Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Pemphigus Vulgaris, historical and forecasted epidemiology as well as the Pemphigus Vulgaris market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
To Know in detail about the Pemphigus Vulgaris market outlook, drug uptake, treatment scenario and epidemiology trends, Click here; Pemphigus Vulgaris Market Forecast
https://www.delveinsight.com/sample-request/pemphigus-vulgaris-market?utm_source=openpr&utm_medium=pressrelease&utm_campaign=gpr
Some of the…
Osteogenesis Imperfecta Market to Evolve Rapidly Over the Next Decade by 2034, D …
The Osteogenesis Imperfecta market is expected to surge due to the disease's increasing prevalence and awareness during the forecast period. Furthermore, launching various multiple-stage Osteogenesis Imperfecta pipeline products will significantly revolutionize the Osteogenesis Imperfecta market dynamics.
DelveInsight's "Osteogenesis Imperfecta Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Osteogenesis Imperfecta, historical and forecasted epidemiology as well as the Osteogenesis Imperfecta market trends in the United…
Myopic Macular Degeneration Market Insights Highlight Expanding Outlook Till 203 …
DelveInsight's "Myopic Macular Degeneration Market Insights, Epidemiology, and Market Forecast-2034′′ report offers an in-depth understanding of the Myopic Macular Degeneration, historical and forecasted epidemiology as well as the Myopic Macular Degeneration market trends in the United States, EU4 (Germany, Spain, Italy, France) the United Kingdom and Japan.
The latest healthcare forecast report provides an in-depth analysis of Myopic Macular Degeneration, offering comprehensive insights into the Myopic Macular Degeneration revenue trends,…
More Releases for Cancer
Cancer Therapeutics Market New Business Opportunities to Hit $180.19 billion by …
Surge in geriatric population and rise in the number of collaborations & partnerships to facilitate drug development are the key drivers of the global cancer therapeutics market. In addition, heavy inflow of investment in R&D activities has enhanced the development of cancer therapeutics. Furthermore, favorable government regulations for cancer therapeutics and surge in cancer prevalence boost the market. The high demand for personalized medicine along with high potential of emerging…
Global Cancer Diagnostics Market Size, Trends & Growth Opportunity By Applicatio …
Cancer diagnostics is a process of detecting various proteins, biomarkers and certain symptoms that result in the detection of presence of cancerous tumour in patients. Detection of certain proteins and biomarkers which are prevalent in cancer disorder thereby results in diagnosis process. Cancer diagnostics includes usage of certain technology and devices for detection purpose.
Increase in incidence of target diseases like cancer is key driving factor which is expected to boost…
2019-2027 Oncology Nutrition Market is driven by Major Cancer Type - Head and Ne …
The "Global Oncology Nutrition Market Analysis to 2027" is a specialized and in-depth study with a special focus on the global market trend analysis. The report aims to provide an overview of oncology nutrition market with detailed market segmentation by cancer type and geography. The global oncology nutrition market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the…
Cancer Immunotherapy Market 2018 To 2025 - SWOT Analysis By Global Industry Reve …
The Cancer Immunotherapy Market research report provided by Crystal Market Research (CMR) is the most detailed study about Cancer Immunotherapy Market that is estimated to grow at a tremendous rate over the forecast period 2018-2025. This report contains precise and updated insights in respect with the leading market players and prevailing regions of the business.
Cancer Immunotherapy Market By Product and Cancer Type - Global Industry Analysis And Forecast To 2025:…
Oncology Nutrition Market by Cancer Type Breast Cancer, Liver Cancer, Lung Cance …
Lunch of new products for nutrition of oncology patients is expected to drive the oncology nutrition market growth. For instance, in 2016, Hormel Food Corporation, a U.S-based meat food products company, launched a line of packaged ready-to-eat meals for cancer patients, which are called as Hormel Vital Cuisine.
These meals consist of carbohydrates, proteins, and fats to help patients fight loss of muscle mass and energy during cancer treatment. Thus launch…
Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung …
Researchmoz added Most up-to-date research on "Tumor Ablation Global Market From 2014 - 2024: Segmented Into Liver Cancer, Lung Cancer, Kidney Cancer, Bone Cancer, Breast Cancer, Prostate Cancer, And Others" to its huge collection of research reports.
Tumor ablation is the removal of the tumor cells or tissue with minimally invasive procedure. Tumor ablation devices are consists of an applicator (catheter), which is introduced into the tumor under imaging guidance. For…
